Search

Search Constraints

You searched for: Author/Creator Presland, Laura

Search Results

1. 120. Impact of a Molecular Point-of-care 'test and Treat' Strategy for Influenza in Hospitalised adults: A Multi-centre, Randomised Controlled Trial (FluPOC). (31st December 2020)

2. 415. Clinical Impact of Molecular Point-of-Care Testing for COVID-19 in Adults Presenting to Hospital: A Prospective, Interventional, Non-Randomised, Controlled Study. (31st December 2020)

3. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10274 (13th February 2021)

4. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022)

5. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022)

6. Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection. Issue 6 (December 2020)

7. Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial. Issue 4 (April 2021)

8. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Issue 12 (December 2020)

9. Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19. Issue 4 (October 2020)

10. Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial. Issue 11 (November 2022)